CRIS Current Research Information System

PALMERINI, EMANUELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.185
AS - Asia 5.944
EU - Europa 5.293
SA - Sud America 464
AF - Africa 356
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 9
Totale 20.268
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.098
SG - Singapore 1.971
VN - Vietnam 1.348
CN - Cina 1.306
GB - Regno Unito 1.250
IT - Italia 919
DE - Germania 880
HK - Hong Kong 665
SE - Svezia 663
BR - Brasile 351
IN - India 336
RU - Federazione Russa 315
IE - Irlanda 236
FR - Francia 224
NL - Olanda 138
ZA - Sudafrica 127
UA - Ucraina 104
CH - Svizzera 99
EE - Estonia 95
KR - Corea 95
CI - Costa d'Avorio 92
TG - Togo 79
FI - Finlandia 76
AT - Austria 61
BG - Bulgaria 57
JO - Giordania 57
AR - Argentina 49
BE - Belgio 42
JP - Giappone 42
CA - Canada 39
ES - Italia 36
PL - Polonia 33
ID - Indonesia 32
EC - Ecuador 27
MX - Messico 26
BD - Bangladesh 20
MA - Marocco 17
SC - Seychelles 16
AU - Australia 14
GR - Grecia 14
MY - Malesia 13
IQ - Iraq 9
RO - Romania 8
BZ - Belize 7
CL - Cile 7
CO - Colombia 7
IR - Iran 7
LT - Lituania 6
NO - Norvegia 6
PE - Perù 6
PY - Paraguay 6
TR - Turchia 6
UZ - Uzbekistan 6
A2 - ???statistics.table.value.countryCode.A2??? 5
CR - Costa Rica 5
NG - Nigeria 5
BO - Bolivia 4
EG - Egitto 4
HU - Ungheria 4
LB - Libano 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
BY - Bielorussia 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
EU - Europa 3
HN - Honduras 3
HR - Croazia 3
LV - Lettonia 3
NZ - Nuova Zelanda 3
SA - Arabia Saudita 3
SI - Slovenia 3
TH - Thailandia 3
AZ - Azerbaigian 2
DK - Danimarca 2
DZ - Algeria 2
ET - Etiopia 2
GA - Gabon 2
KE - Kenya 2
KW - Kuwait 2
KZ - Kazakistan 2
NI - Nicaragua 2
TN - Tunisia 2
VE - Venezuela 2
AD - Andorra 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
CY - Cipro 1
DJ - Gibuti 1
GH - Ghana 1
GY - Guiana 1
HT - Haiti 1
IL - Israele 1
IS - Islanda 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
ME - Montenegro 1
Totale 20.254
Salva come PNG Salva come JPEG
Città #
Singapore 1.289
Southend 1.104
Ashburn 927
Fairfield 860
Chandler 760
Hong Kong 660
Woodbridge 463
Wilmington 416
Seattle 370
Santa Clara 349
Ann Arbor 346
Houston 345
Princeton 332
Cambridge 292
Dong Ket 261
Hanoi 259
Ho Chi Minh City 258
Beijing 250
Dublin 236
Boardman 221
Hefei 144
Frankfurt am Main 137
Bologna 126
Westminster 110
Nanjing 109
Padova 104
Los Angeles 101
Abidjan 92
Seoul 89
Bern 86
Buffalo 84
Lomé 79
Berlin 77
Turin 73
Redmond 69
Dallas 65
Milan 64
Redondo Beach 61
San Diego 60
Saint Petersburg 58
Amman 57
Bremen 57
Helsinki 54
New York 52
Sofia 51
Medford 48
Shenyang 47
Falls Church 43
Munich 43
Des Moines 42
Jinan 42
Brussels 40
São Paulo 40
Dearborn 39
Hebei 38
Rome 37
Nanchang 34
Tokyo 34
Vienna 32
Changsha 31
Chicago 31
Da Nang 30
San Jose 29
Guangzhou 28
Shanghai 27
Nuremberg 26
Düsseldorf 25
Haiphong 25
Jacksonville 25
Falkenstein 24
Norwalk 21
London 20
Zhengzhou 20
Tianjin 19
Ha Long 18
Jiaxing 18
San Francisco 18
Florence 17
Quận Bình Thạnh 17
Warsaw 17
Biên Hòa 16
Hangzhou 16
Hải Dương 16
Redwood City 16
Bari 15
Bengaluru 15
Brooklyn 15
Phoenix 15
Jakarta 14
Lappeenranta 14
Quận Một 14
Toronto 14
Yubileyny 14
Haikou 13
Stockholm 13
Thái Nguyên 13
Atlanta 12
Bühl 12
Casablanca 12
Chengdu 12
Totale 13.383
Salva come PNG Salva come JPEG
Nome #
Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic 380
Abstract 5909: IDH mutations in G2-3 conventional chondrosarcoma of bone: a mono institutional experience 248
Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study 228
Integrated molecular characterization of patient-derived models reveals therapeutic strategies for treating CIC-DUX4 sarcoma 226
Excision repair cross-complementation group 1 protein expression predicts survival in patients with high-grade, non-metastatic osteosarcoma treated with neoadjuvant chemotherapy 217
Prognostic and predictive role of CXCR4, IGF-1R and Ezrin expression in localized synovial sarcoma: is chemotaxis important to tumor response? 216
Preoperative nasopharyngeal swab testing and postoperative pulmonary complications in patients undergoing elective surgery during the SARS-CoV-2 pandemic 215
A phase 2 trial of imatinib mesylate in patients with recurrent nonresectable chondrosarcomas expressing platelet-derived growth factor receptor-α or -β 211
SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study 210
CIC-DUX4 fusion-positive round-cell sarcomas of soft tissue and bone: A single-institution morphological and molecular analysis of seven cases 205
A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: An Italian sarcoma group study 194
Toxicity and efficacy of busulfan-melphalan (BuMel) compared to treosulfan-melphalan (TreoMel) high dose chemotherapy (HDCT) consolidation in high-risk Ewing sarcoma (ES): A 12-year monoinstitutional experience 185
Predictive factors of histologic response to primary chemotherapy in patients with ewing sarcoma 184
Delaying surgery for patients with a previous SARS-CoV-2 infection 180
Case report: temozolomide induced partial response in a primary diffuse leptomeningeal gliomatosis patient. 179
Advances in treatment for tenosynovial giant cell tumors 179
Gemcitabine and docetaxel in relapsed and unresectable high-grade osteosarcoma and spindle cell sarcoma of bone 170
Prognostic significance of immunohistochemical expression of ezrin in non-metastatic high-grade osteosarcoma 170
Chondrosarcomas revisited. 169
Denosumab in advanced/unresectable giant-cell tumour of bone (GCTB): For how long? 169
Tumoral immune-infiltrate (IF), PD-L1 expression and role of CD8/TIA-1 lymphocytes in localized osteosarcoma patients treated within protocol ISG-OS1 168
Osteosarcoma follow-up: chest X-ray or computed tomography? 165
A Mass with High Uptake of Fluorodeoxyglucose on Positron Emission Tomography 164
Carboplatin and etoposide (CE) chemotherapy in patients with recurrent or progressive oligodendroglial tumors 163
Adjuvant and neoadjuvant combination chemotherapy for osteogenic sarcoma 161
Diagnosis and prognosis for the Ewing family of tumors 161
The role of FDG PET/CT in patients treated with neoadjuvant chemotherapy for localized bone sarcomas 160
Pazopanib in relapsed osteosarcoma patients: report on 15 cases 160
Eribulin in advanced liposarcoma and leiomyosarcoma 159
SELNET clinical practice guidelines for soft tissue sarcoma and GIST 159
Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial. 158
Tenosynovial giant cell tumor (TGCT)/pigmented villonodular synovitis (PVNS): Outcome of 313 patients before the era of kinase inhibitors 157
Does MGMT (O6-methylguanine–DNA methyltransferase) have a role in metastatic Ewing sarcoma (ES) patients (pts) undergoing temozolomide (TMZ) and irinotecan (IRI)? 157
A simple prognostic scoring system for non metastatic osteosarcoma of the extremity 156
Chemotherapy-related toxicity in patients with non-metastatic Ewing sarcoma: influence of sex and age 155
Bone marrow biopsy in the initial staging of Ewing sarcoma: Experience from a single institution 154
Irinotecan and temozolomide in recurrent Ewing sarcoma: an analysis in 51 adult and pediatric patients 151
Advanced chondrosarcomas: Role of chemotherapy and survival 150
Bone Turnover Marker (BTM) Changes after Denosumab in Giant Cell Tumors of Bone (GCTB): A Phase II Trial Correlative Study 148
Prognosis of radiation-induced bone sarcoma is similar to primary osteosarcoma 147
Ewing sarcoma in patients over 40 years of age: A prospective analysis of 31 patients treated at a single institution 147
CXCR4 in human osteosarcoma malignant progression. The response of osteosarcoma cell lines to the fully human CXCR4 antibody MDX1338 146
ABCB1/P-glycoprotein (Pgp) expression as stratification factor for treatment of patients with non metastatic extremity high grade osteosarcoma: An Italian Sarcoma Group (ISG) multicentric prospective trial (ISG/OS-2) 145
Emerging therapeutic targets for synovial sarcoma 140
Local and systemic control of Ewing's bone sarcoma family tumors of the ribs 139
Immune-infiltrate characterization in localized osteosarcoma patients treated within protocol ISG-OS1. 138
The treatment of nonmetastatic high grade osteosarcoma of the extremity: review of the italian Rizzoli experience. Impact on the future. 138
Extraskeletal myxoid chondrosarcoma: A retrospective analysis of 69 patients with localized disease and molecularly confirmed diagnosis. 137
High dose ifosfamide in metastatic high-grade osteosarcoma, after failure of standard multimodal chemotherapy. 137
Whole lung irradiation after high‐dose busulfan/melphalan in ewing sarcoma with lung metastases: An Italian sarcoma group and associazione Italiana ematologia oncologia pediatrica joint study 137
Response to high-dose ifosfamide in patients with advanced/recurrent ewing sarcoma 136
Synovial sarcoma: Is chemotaxis important to tumor progression? 136
Angiosarcoma of bone: a retrospective study of the European Musculoskeletal Oncology Society (EMSOS) 136
The natural history of advanced inoperable central chondrosarcoma 135
The role of 18F-FDG PET/CT in the detection of osteosarcoma recurrence. 135
Phase ii study on lapatinib in advanced egfr-positive chordoma 134
CIC-DUX4 Fusion-Positive Round Cell Sarcomas of Soft Tissue and Bone: Clinicopthologic and Molecular Analysis from a Single Institution 134
A nonrandomized phase II trial of sorafenib (S) and everolimus (E) in unresectable metastatic osteosarcoma (OST) patients (pts) relapsed after standard chemotherapy. 133
Osteosarcoma of the pelvis: A monoinstitutional experience in patients younger than 41 years 133
Sorafenib and everolimus for patients with unresectable high-grade osteosarcoma progressing after standard treatment: A non-randomised phase 2 clinical trial 133
Sex- and age-related chemotherapy toxicity in patients with non-metastatic osteosarcoma 132
Feasibility of preoperative chemotherapy with or without radiation therapy in localized soft tissue sarcomas of limbs and superficial trunk in the Italian sarcoma group/grupo español de investigación en sarcomas randomized clinical trial: Three versus five cycles of full-dose epirubicin plus ifosfamide 132
High grade osteosarcoma of the extremities with lung metastases at presentation: treatment with neoadjuvant chemotherapy and simultaneous resection of primary and metastatic lesions. 131
Spontaneous regression of lung metastasis from osteosarcoma: A case report 131
Osteosarcoma of the pelvis and sacrum: A retrospective analysis of 73 patients. 129
Sinusoidal obstruction syndrome/veno-occlusive disease after high-dose intravenous busulfan/melphalan conditioning therapy in high-risk Ewing Sarcoma 126
Non-surgical treatment of chondrosarcoma: Current concepts and future perspectives 125
Irinotecan and temozolomide upfront and in relapsed Ewing sarcoma: A translational study on MGMT (O6-methylguanine–DNA methyltransferase) and ABCG2 (MGMTLiberati) 125
Neoadjuvant denosumab treatment of locally advanced giant cell tumor of bone (GCTB). 124
Angiosarcoma of bone: A European Muscoloskeletal Oncology Society (EMSOS) multicenter, retrospective study 124
High Dose Ifosfamide in Relapsed and Unresectable High-Grade Osteosarcoma Patients: A Retrospective Series 122
A four-arm randomized phase II trial with NGR-hTNF given at low or high dose with or without doxorubicin in soft tissue sarcomas (STS). 121
Neoadjuvant chemotherapy with methotrexate, cisplatin, and doxorubicin with or without ifosfamide in nonmetastatic osteosarcoma of the extremity: An Italian Sarcoma Group Trial ISG/OS-1 121
Metastatic spread to bone: The role of chemotherapy 120
Analysis of risk factors for central venous catheter-related complications: a prospective observational study in pediatric patients with bone sarcomas 120
Neoadjuvant chemotherapy for osteosarcoma of the extremities in preadolescent patients: The rizzoli institute experience 120
Phase II trial of carboplatin and etoposide for patients with recurrent high-grade glioma 120
Outcome in dedifferentiated chondrosarcoma for patients treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study 120
Treatment and prognosis for synchronous multifocal osteosarcoma in 42 patients 119
Anthracycline, gemcitabine, and pazopanib in epithelioid sarcoma: Results of a retrospective multi-institutional case series. 119
Synovial sarcoma: Retrospective analysis of 250 patients treated at a single institution 119
Second malignant neoplasm in patients with osteosarcoma of the extremities treated with adjuvant and neoadjuvant chemotherapy 118
Primary Angiosarcoma of Bone: A Retrospective Analysis of 60 Patients From 2 Institutions 118
Fibrosarcomatous changes and expression of CD34+ and apolipoprotein-D in dermatofibrosarcoma protuberans. 118
Periosteal osteosarcoma: a single-institution experience. 118
Palliative embolisation for advanced bone sarcomas. 118
Phase 2 study for nonmetastatic extremity high-grade osteosarcoma in pediatric and adolescent and young adult patients with a risk-adapted strategy based on ABCB1/P-glycoprotein expression: An Italian Sarcoma Group trial (ISG/OS-2) 117
Gemcitibine (G) and docetaxel (D) in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy. 116
Long-term treatment of giant cell tumors of bone (GCTB) with denosumab: a two institutions 8-year experience. 116
PD1 and PDL1 expression, tumoral microenvironment (TME) characterization and clinical implication in localized osteosarcoma 116
Sunitinib Exerts In Vitro Immunomodulatory Activity on Sarcomas via Dendritic Cells and Synergizes With PD-1 Blockade 116
Two doses of NGR-hTNF (N) given alone or in combination with doxorubicin (D) in soft tissue sarcomas (STS). 115
Is there a role for chemotherapy after local relapse in high-grade osteosarcoma? 115
Temozolamide and irinotecan in metastatic Ewing sarcoma: An Italian Sarcoma Group and Royal Marsden Hospital join study. 114
miR-494.3p expression in synovial sarcoma: Role of CXCR4 as a potential target gene 114
FDG PET/CT IN PATIENTS TREATED WITH NEOADJUVANT CHEMOTHERAPY FOR LOCALIZED BONE SARCOMAS 113
International single-arm phase II trial of pazopanib in advanced extraskeletal myxoid chondrosarcoma: A Collaborative Spanish (GEIS), Italian (ISG) and French (FSG) Sarcoma Groups study. 113
Imaging in bone sarcomas. the chemotherapist's point of view 112
Pazopanib in metastatic osteosarcoma patients: Report of 9 cases treated off label at Rizzoli Orthopedic Institute 112
Lapatinib in advanced chordoma: A phase II study. 112
Totale 14.828
Salva come PNG Salva come JPEG
Categoria #
all - tutte 62.240
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.240
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.120 0 0 0 0 0 41 44 118 144 124 82 567
2021/20222.826 231 70 166 150 326 160 68 251 164 223 489 528
2022/20233.336 356 470 247 423 225 238 121 188 525 125 207 211
2023/2024792 51 154 65 65 48 91 56 50 25 62 44 81
2024/20253.577 154 608 273 245 582 179 205 94 67 224 131 815
2025/20264.287 855 876 647 539 880 490 0 0 0 0 0 0
Totale 20.733